Skip to Main

Search

Results 831 to 840 of 978 for ""

Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/hard-to-treat-cancers.html

A compound synthesized by a team led by UT Southwestern scientists kills a range of hard-to-treat cancer types by targeting a previously unexploited vulnerability, a new study reports.

UTSW study: RNA exosome key for B cell development: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/rna-exosome-key.html

New research from UT Southwestern suggests that RNA exosomes– the cellular machines that degrade old molecules of RNA – play a key role in the development of B cells, which are critical to the immune system’s ability to protect against infection.

UTSW researchers develop microbubble technology to enhance cancer immunotherapy : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/microbubble-technology.html

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

UTSW infectious diseases experts offer advice on second COVID-19 booster : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/second-booster.html

Individuals should weigh their own personal health and risk levels in deciding when to receive a second booster of the COVID-19 vaccine, UT Southwestern infectious diseases experts advise.

Tackling resistance to HIF2 drugs with an RNA-based therapy: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-resistance-to-hif2-drugs.html

Expected to be diagnosed in 2% of men and 1% of women in the U.S., kidney cancer has traditionally been one of the most challenging cancers to treat.

Mothers with diabetes can have a healthy breastfeeding experience: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-mothers-with-diabetes.html

Breastfeeding offers a wealth of benefits both for mothers and their babies. Although diabetes can complicate the process, it does not prevent mothers from giving their babies this wonderful start to life, according to UT Southwestern endocrinologist Maria Ramos-Roman, M.D., Associate Professor of

UTSW researchers discover molecular switch for heart regeneration: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-heart-regeneration.html

Scientists at UT Southwestern have discovered a molecular switch to restore the regenerative ability of adult heart cells.

UT Southwestern ranked No. 1 in Texas, fourth in nation for tech transfer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-tech-transfer.html

UT Southwestern Medical Center ranked fourth in the nation and No. 1 in Texas for commercializing new biomedical technologies, considered a critical step in bringing its laboratory discoveries into clinical practice.

How parents can help their kids with asthma avoid serious attacks: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-kids-with-asthma.html

Changes in weather that accompany the return to school each fall can create a challenging environment for children who suffer from asthma, the most common pediatric chronic illness.

“Bionic pancreas” improves blood sugar control in Type 1 diabetics: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-bionic-pancreas.html

An experimental device known as a bionic pancreas kept blood sugar levels within normal ranges more effectively than standard-of-care glucose management among patients with Type 1 diabetes in a multicenter trial conducted partly at UT Southwestern.